Trevi Therapeutics, Inc. TRVI Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s operating lease right-of-use asset amortization?
- Trevi Therapeutics, Inc. (TRVI) reported operating lease right-of-use asset amortization of $105K in Q1 2026.
- How has Trevi Therapeutics, Inc.'s operating lease right-of-use asset amortization changed year-over-year?
- Trevi Therapeutics, Inc.'s operating lease right-of-use asset amortization decreased by 6.3% year-over-year, from $112K to $105K.